Dr. Bajaj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3215
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
Karmanos Cancer CenterMD, Hematology/Oncology, 2009 - 2012
University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2005 - 2008
Saba University School of MedicineClass of 2004- University of Illinois BS, Molecular and Integrative Physiology , Honors Distinction, 1995 - 1999
Certifications & Licensure
CA State Medical License 2024 - 2026
IL State Medical License 2012 - 2026
MI State Medical License 2008 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer Start of enrollment: 2015 May 01
- A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma Start of enrollment: 2017 Jan 12
Publications & Presentations
PubMed
- 259 citationsOlanzapine for the Prevention of Chemotherapy-Induced Nausea and VomitingRudolph M. Navari, Rui Qin, Kathryn J. Ruddy, Heshan Liu, Steven F. Powell
The New England Journal of Medicine. 2016-07-13 - 157 citationsCombination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.Michael B Atkins, Sandra J Lee, Bartosz Chmielowski, Ahmad A Tarhini, Gary I Cohen
Journal of Clinical Oncology. 2023-01-10 - 94 citationsPembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in MelanomaDaniel J Olson, Zeynep Eroglu, Bruce Brockstein, Andrew Poklepovic, Madhuri Bajaj
Journal of Clinical Oncology. 2021-05-04
Press Mentions
A Big Hole and Cutting-Edge Ideas as OSF HealthCare Begins Work on New Cancer InstituteAugust 17th, 2021
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Telugu, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
